Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

New Workstation Provides Superior Pipetting Performance with Advanced Technologies

By BiotechDaily International staff writers
Posted on 01 Oct 2013
Image: The new VANTAGE liquid handling workstation from Hamilton Robotics (Photo courtesy of Hamilton Robotics).
Image: The new VANTAGE liquid handling workstation from Hamilton Robotics (Photo courtesy of Hamilton Robotics).
A new liquid handling platform provides superior performance for simple to complex pipetting needs, plus an integration option to simplify laboratory automation.

Hamilton Robotics (Reno, NV, USA) now offers the “Vantage” workstation, a highly flexible, multipurpose pipetting platform featuring a completely new, state-of-the-art linear motor design and contact-free NanoPulse pipetting technology covering a wide volume range (100 nL–1 mL). This affordable liquid handler is space-efficient and enables users to prepare samples with the utmost precision and traceability, helping to ensure downstream data reliability.

"The Hamilton VANTAGE caters to all market needs, from a low-cost pipettor to the most complex integrated system, and is field upgradable to cover the entire usability pyramid," said Jose Carle, vice president of Hamilton Robotics. Its expandable design also makes it a valuable instrument for labs with growing needs or new applications. Labs requiring increased walk-away time, high throughputs, or large capacities can upgrade their bench-top VANTAGE pipettor at any time with a Logistics Cabinet, which offers innovative tip and plate shuttling from below the pipetting deck and customizable, smart waste solutions.

A telescopic, vertical Track Gripper can also be added to transport samples from below- or off-deck third-party devices such as thermal cyclers, centrifuges, washers, readers, sealers, peelers, and incubators. "A single vertically integrated system can easily replace four to six other pipetting robots and offers much more functionality than competitor's platforms," said Alvaro Cuevas, VANTAGE Senior Product Manager. “Overall, this saves customers money and enables them to build process redundancy with a second robot at the same price point."

In addition to the hardware, INSTINCT V software brings ease of use to the next level with automation intelligence, making VANTAGE accessible to varying user levels. The graphical Assay Editor allows a user to program in a "lab person's language" while the XSL Editor can be used for more complex programming tasks. INSTINCT V's resource-optimized, dynamic Scheduler allows users to run the same or different assays in parallel on an instrument while other users connect remotely to write methods for new assays. INSTINCT V also provides remote system monitoring via smart phones, tablets, or any web-enabled device, which increases walk-away time for overnight and weekend runs.

Related Links:
Hamilton Robotics
VANTAGE Workstation



view channel
Image: A new catalyst that improved the sensitivity of the standard PSA ELISA test by about 110-fold was made of palladium nanocubes coated with iridium (Photo courtesy of Dr. Xiaohu Xia, Michigan Technological University).

Peroxidase Mimic Outperforms Natural Horseradish Peroxidase in ELISA Test

A test-of-concept study demonstrated that a synthetic catalyst that mimics the action of horseradish peroxidase (HRP) could increase the sensitivity of a colorimetric enzyme-linked immunosorbent assay... Read more

Drug Discovery

view channel
Image: Endoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places (Photo courtesy of Wikimedia Commons).

Orally Delivered Curcumin-Loaded Microparticles Effectively Treat Mouse Model of Ulcerative Colitis

Microparticles (MPs) loaded with the efficient anti-inflammatory agent curcumin were found to effectively treat a mouse model of ulcerative colitis. Ulcerative colitis is a chronic relapsing disease... Read more


view channel

Biopharmaceutical Partners Seek Alternatives to Glucocorticoid Steroid Drugs

Collaboration between American and Japanese biopharmaceutical companies is expected to lead to the development of a new class of small molecule drugs for treatment of hematological and inflammatory diseases. Gencia LLC (Charlottesville, VA, USA) and Takeda Pharmaceutical Company Ltd. (Osaka, Japan) announced the formation... Read more


17 Oct 2015 - 21 Oct 2015
25 Oct 2015 - 29 Oct 2015
16 Nov 2015 - 19 Nov 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.